Literature DB >> 16395674

Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.

M Goldberg1, C Rummelt, S Foja, L M Holbach, W G Ballhausen.   

Abstract

Periocular sebaceous gland carcinomas (SGCs) occur in the eyelids either sporadically or as a phenotypic feature of Muir-Torre syndrome (MTS). In knockout mice mismatch-repair (MMR) defects or inactivation of the fragile histidine triad (FHIT) gene are associated with MTS-like signs, including SGC. To dissect the genetic alterations associated with microsatellite instability (MSI) and inactivation of the FHIT gene, we studied nine periocular SGC specimens from MTS patients. Immunohistochemistry was performed for FHIT, MSH2, MLH1, and MSH6. We assessed MSI as well as loss of heterozygosity (LOH) at the FHIT locus with polymorphic markers and genomic multiplex PCR. Epigenetic silencing was detected by methylation-specific PCR (MSP) and combined bisulfite restriction analysis (COBRA). Our analyses identified two SGCs with FHIT positivity and high-grade MSI, and seven cases with loss of FHIT and microsatellite stability (MSS). MSI correlated with loss of MSH2 and MLH1 immunostaining. Loss-of-function mechanisms affecting the FHIT gene were identified as intragenic deletions eliminating the coding exons 5 and 6 on one hand, and complete biallelic methylation of the FHIT transcription regulatory region on the other hand. Germinal FHIT mutations as a predisposing factor for MTS were excluded in two index patients with cancer in three generations, including an FHIT-negative SGC. Our data suggest that either somatic inactivation of the FHIT gene associated with MSS or inactivation of the MMR system resulting in MSI contribute to the development of periocular SGCs in presumptive MTS. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395674     DOI: 10.1002/humu.20281

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  [Differential diagnosis and treatment options for conjunctival tumors].

Authors:  L M Holbach; P Pogorelov; F E Kruse
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

Review 2.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

3.  [Recurrent eyelid tumors with different dignities].

Authors:  U Löw; C S L Müller; E Zemova; F A Flockerzi; B Seitz
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

4.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

5.  Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Authors:  Daniel L Kiss; Catherine E Waters; Iman M Ouda; Joshua C Saldivar; Jenna R Karras; Zaynab A Amin; Seham Mahrous; Teresa Druck; Ralf A Bundschuh; Daniel R Schoenberg; Kay Huebner
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-14       Impact factor: 4.490

Review 6.  [Therapy options for malignant eyelid tumors].

Authors:  M Weiling; A Bergua; F E Kruse; L Holbach
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

7.  Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients.

Authors:  Sabrina Titze; Hartmut Peters; Sandra Währisch; Thomas Harder; Katrin Guse; Annegret Buske; Sigrid Tinschert; Anja Harder
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

Review 8.  The FHIT gene product: tumor suppressor and genome "caretaker".

Authors:  Catherine E Waters; Joshua C Saldivar; Seyed Ali Hosseini; Kay Huebner
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

9.  Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice.

Authors:  Sergey G Kuznetsov; Diana C Haines; Betty K Martin; Shyam K Sharan
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

Review 10.  Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.

Authors:  Maya Eiger-Moscovich; Ralph C Eagle; Carol L Shields; Hilary Racher; Sara E Lally; Rona Z Silkiss; Jerry A Shields; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.